Gourgou S - Search Results

1

Prospective memory and brain metastases: a relevant target for rehabilitation in post-operative patients?

Guerdoux-Ninot E, Bauchet L, Legninda Sop FY, Gourgou S, Gomez A, Gerazime A, Darlix A, Ninot G. Guerdoux-Ninot E, et al. Among authors: gourgou s. J Neurooncol. 2020 Mar;147(1):185-194. doi: 10.1007/s11060-020-03414-x. Epub 2020 Jan 30. J Neurooncol. 2020. PMID: 31997234

2

Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the "APAD1" randomized controlled trial.

Carayol M, Ninot G, Senesse P, Bleuse JP, Gourgou S, Sancho-Garnier H, Sari C, Romieu I, Romieu G, Jacot W. Carayol M, et al. Among authors: gourgou s. BMC Cancer. 2019 Jul 25;19(1):737. doi: 10.1186/s12885-019-5896-6. BMC Cancer. 2019. PMID: 31345179 Free PMC article. Clinical Trial.

3

Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial.

Jacot W, Arnaud A, Jarlier M, Lefeuvre-Plesse C, Dalivoust P, Senesse P, Azzedine A, Tredan O, Sadot-Lebouvier S, Mas S, Carayol M, Bleuse JP, Gourgou S, Janiszewski C, Launay S, D'Hondt V, Lauridant G, Grenier J, Romieu G, Ninot G, Vanlemmens L. Jacot W, et al. Among authors: gourgou s. Nutrients. 2020 Oct 9;12(10):3081. doi: 10.3390/nu12103081. Nutrients. 2020. PMID: 33050321 Free PMC article. Clinical Trial.

4

Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD.

Bascoul-Mollevi C, Savina M, Anota A, Barbieri A, Azria D, Bonnetain F, Gourgou S. Bascoul-Mollevi C, et al. Among authors: gourgou s. Comput Methods Programs Biomed. 2018 May;158:153-159. doi: 10.1016/j.cmpb.2018.02.010. Epub 2018 Feb 17. Comput Methods Programs Biomed. 2018. PMID: 29544781

5

Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results.

Bascoul-Mollevi C, Barbieri A, Bourgier C, Conroy T, Chauffert B, Hebbar M, Jacot W, Juzyna B, De Forges H, Gourgou S, Bonnetain F, Touraine C, Anota A. Bascoul-Mollevi C, et al. Among authors: gourgou s. Qual Life Res. 2021 Jan;30(1):91-103. doi: 10.1007/s11136-020-02605-3. Epub 2020 Aug 18. Qual Life Res. 2021. PMID: 32809099

6

Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials.

Cuer B, Conroy T, Juzyna B, Gourgou S, Mollevi C, Touraine C. Cuer B, et al. Among authors: gourgou s. Qual Life Res. 2022 May;31(5):1359-1370. doi: 10.1007/s11136-021-03040-8. Epub 2021 Nov 24. Qual Life Res. 2022. PMID: 34817733 Free article. Clinical Trial.

7

The importance of using ordinal scores for patient classification based on health-related quality of life trajectories.

Barbieri A, Cousson-Gélie F, Baussard L, Gourgou S, Lavergne C, Mollevi C. Barbieri A, et al. Among authors: gourgou s. Pharm Stat. 2022 Sep;21(5):919-931. doi: 10.1002/pst.2205. Epub 2022 Mar 15. Pharm Stat. 2022. PMID: 35289497

8

When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials.

Touraine C, Cuer B, Conroy T, Juzyna B, Gourgou S, Mollevi C. Touraine C, et al. Among authors: gourgou s. BMC Med Res Methodol. 2023 Feb 10;23(1):36. doi: 10.1186/s12874-023-01846-3. BMC Med Res Methodol. 2023. PMID: 36765307 Free PMC article.

9

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.

Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez-Nebout N, Vendrely V, Artignan X, Bouché O, Gargot D, Boige V, Bonichon-Lamichhane N, Louvet C, Morand C, de la Fouchardière C, Lamfichekh N, Juzyna B, Jouffroy-Zeller C, Rullier E, Marchal F, Gourgou S, Castan F, Borg C; Unicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group. Conroy T, et al. Among authors: gourgou s. Lancet Oncol. 2021 May;22(5):702-715. doi: 10.1016/S1470-2045(21)00079-6. Epub 2021 Apr 13. Lancet Oncol. 2021. PMID: 33862000 Clinical Trial.

10

Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study.

Michalet M, Bordeau K, Cantaloube M, Valdenaire S, Debuire P, Simeon S, Portales F, Draghici R, Ychou M, Assenat E, Dupuy M, Gourgou S, Colombo PE, Carrere S, Souche FR, Aillères N, Fenoglietto P, Azria D, Riou O. Michalet M, et al. Among authors: gourgou s. Front Oncol. 2022 Mar 9;12:842402. doi: 10.3389/fonc.2022.842402. eCollection 2022. Front Oncol. 2022. PMID: 35356227 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters